Oversold Stocks in Consumer Staples Present Buying Opportunities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 13 2026
0mins
Should l Buy COTY?
Source: Benzinga
- Oversold Stocks Overview: According to Benzinga Pro, major players in the consumer staples sector, including NU Skin Enterprises Inc, Coty Inc, and Honest Company Inc, have relative strength indices (RSI) near or below 30, indicating they are significantly oversold and may present undervalued buying opportunities for investors.
- RSI Indicator Analysis: The relative strength index (RSI) serves as a momentum indicator that compares a stock's strength on up days versus down days, helping traders better assess short-term stock performance and make more informed investment decisions amid market fluctuations.
- Market Opportunity Identification: The identification of oversold stocks in the current market environment offers potential appreciation opportunities for investors, particularly in the consumer staples sector, where investors can capitalize on the rebound potential of these undervalued stocks.
- Investment Strategy Recommendations: While Benzinga does not provide investment advice, the phenomenon of oversold stocks typically attracts value-seeking traders, suggesting a focus on the subsequent performance of these stocks to evaluate their rebound potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.470
Low
2.50
Averages
4.30
High
10.00
Current: 2.470
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit following its Q2 2026 earnings report, which revealed serious operational issues and the abrupt departure of CEO Sue Y. Nabi, representing investors who purchased shares between November 5, 2025, and February 4, 2026, indicating significant investor dissatisfaction with the company's transparency.
- Stock Price Impact: Following the earnings report on February 5, 2026, Coty's stock price dropped over 8% that day, reflecting market concerns about the company's future profitability, particularly as the Consumer Beauty segment's operating income plummeted over 70% year-over-year, severely undermining investor confidence.
- Management Changes: The sudden departure of CEO Nabi on December 12, 2025, without explanation, led to a decline in investor confidence regarding corporate governance and future strategy, exacerbating negative sentiment towards Coty and prompting investigations by shareholder rights firms like Hagens Berman.
- Financial Guidance Withdrawal: Coty withdrew its FY 2026 EBITDA and free cash flow guidance during the earnings call, with management projecting mid-single-digit revenue declines for Q3, highlighting the severe challenges the company faces in a competitive market, which could impact its long-term growth potential.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, to apply as lead plaintiffs by May 22, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Participants can join without any upfront costs, as the law firm operates on a contingency fee basis, ensuring that investors receive legal support without financial burden.
- Lawsuit Background: The lawsuit alleges that Coty made false or misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which led to investor losses when the truth emerged.
- Law Firm's Strength: Rosen Law Firm specializes in securities class actions and has achieved significant settlements, recovering over $438 million for investors in 2019 alone, demonstrating its strong expertise and track record in this field.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Coty Inc. to recover damages for investors who purchased Coty securities between November 5, 2025, and February 4, 2026, reflecting investor disappointment in the company's future prospects.
- False Statements Allegations: The complaint alleges that Coty executives made materially false and misleading statements regarding the company's growth and profitability, failing to disclose the underperformance in its Consumer Beauty segment and the slowing growth in the beauty market.
- Profit Pressure Evident: The lawsuit highlights that Coty's margins were pressured by increased marketing expenditures, which negatively impacted overall profitability and heightened investor concerns about the company's financial health.
- No Cost to Investors: Bronstein, Gewirtz & Grossman, LLC emphasizes that they operate on a contingency fee basis, meaning investors incur no costs unless the lawsuit is successful, thereby lowering the barrier for investor participation in the class action.
See More
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased its stock between November 5, 2025, and February 4, 2026, following a Q2 2026 earnings report that revealed serious operational issues, causing the stock price to drop over 8% on the announcement day.
- Executive Departure: The abrupt departure of CEO Sue Y. Nabi on December 12, 2025, without explanation, has raised significant concerns regarding corporate governance and transparency, exacerbating investor anxiety about the company's future.
- Deteriorating Financial Performance: The Q2 2026 earnings report revealed that Coty's Consumer Beauty segment operating income plummeted over 70% year-over-year, while Prestige fragrance income fell over 18%, indicating severe challenges in market competitiveness and operational efficiency.
- Investor Confidence Eroded: Coty withdrew its FY 2026 EBITDA and free cash flow guidance, with management projecting mid-single-digit revenue declines for Q3, highlighting significant uncertainties regarding the company's profitability and market share moving forward.
See More
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit following its Q2 2026 earnings report, which revealed serious operational issues, representing investors who purchased shares between November 5, 2025, and February 4, 2026, indicating strong investor dissatisfaction with the company's transparency.
- Stock Price Impact: Following the abrupt departure of CEO Nabi, Coty's stock price fell over 8% on February 5, 2026, reflecting market pessimism regarding the company's future prospects, particularly after its performance failed to meet expectations.
- Financial Performance: The Q2 2026 report revealed that Consumer Beauty's operating income plummeted over 70% year-over-year, while Prestige fragrance operating income also fell over 18%, highlighting significant challenges the company faces in a competitive market.
- Investigation Progress: Hagens Berman is investigating whether Coty intentionally misled investors regarding its business trends, and if proven, this could have substantial implications for the company's reputation and future financing capabilities.
See More
- Lawsuit Reminder: The Schall Law Firm is reminding investors of a class action lawsuit against Coty Inc. for violations of securities laws, concerning securities transactions from November 5, 2025, to February 4, 2026, with a deadline to contact the firm by May 22, 2026, to participate.
- False Statements: The complaint alleges that Coty made false and misleading statements regarding its growth prospects for fiscal year 2026, as the company’s Consumer Beauty segment was underperforming, leading to significant investor losses.
- Market Reaction: As the market became aware of Coty's true performance, investor losses intensified, indicating a significant discrepancy between the company's growth promises and actual market performance, which negatively impacted its stock price and investor confidence.
- Legal Consequences: The case has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act may become absent class members, potentially forfeiting their claims.
See More











